DIRECTOR AGREEMENTDirector Agreement • October 12th, 2017 • Immudyne, Inc. • Medicinal chemicals & botanical products • Texas
Contract Type FiledOctober 12th, 2017 Company Industry JurisdictionThis DIRECTOR AGREEMENT ("Agreement") is dated as of October 1, 2017, between IMMUDYNE, INC., a Delaware corporation (the "Company"), and Michael T. Borenstein, MD, PHD ("Director''). The Company and the Director are hereinafter sometimes referred to collectively as the "Parties" and individually as a "Party."